Partner Headlines - ESRX

  1. Baird Remains Buyers Of Gilead Before Earnings Release

    Benzinga
  2. Cramer Gives His Opinion On Whole Foods Market, Whiting Petroleum ...

    Benzinga
  3. AmerisourceBergen Hits New High On Earnings, Outlook

    IBD
  4. Has Gilead Sciences Been Able To Maintain Its Lead Run In The ...

    GuruFocus
  5. Gilead, AbbVie Hepatitis C Price Cuts Will Hit Sales

    IBD
  6. Why Drug Pricing Could Bring Volatility To The Biotech Sector ...

    Benzinga
  7. Aetna Sides With Gilead In Hepatitis C Drug Battle

    IBD
  8. What The Market's Reading: An Iraq Ramp-Up & Biotech Moves

    Benzinga
  9. Steven Romick Buys 7 US and International Stocks in Q4

    GuruFocus
  10. Express Scripts Eyes New Price War: Anti-PCSK9 Drugs

    IBD
  11. Cholesterol Drug Costs Eyed

    IBD
  12. AbbVie Inc.'s Forthcoming Future Looks Optimistic

    GuruFocus
  13. Amgen's Decline May Be Linked To Comments Of Express Script's ...

    Benzinga
  14. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  15. AbbVie Stock Down After Guidance, Downgrade

    IBD
  16. Gilead Strikes Deal with CVS, Hits Back AbbVie

    GuruFocus
  17. Hepatitis Drugs Vie For Share

    IBD
  18. CVS Covering Gilead HCV Drugs, Countering AbbVie

    IBD
  19. Stocks Lose More Ground; Gilead Sciences Rises

    IBD
  20. CVS Picks Gilead Hep C Drugs As Price War Looms

    IBD
  21. Drug Distributor Reaps The Rewards Of Strategy Shift

    IBD
  22. Express Scripts Stock Dominated Q4; Which Funds Might've Won?

    Benzinga
  23. 5 Biotech Stocks With Big News Due In January

    IBD
  24. Stocks Hold Near Highs; LifeLock Breaks Out

    IBD
  25. Facebook Among IBD 50's Top 5 Earnings Kings In 2014

    IBD
  26. IBD 50: Biotechs Hammered, Then Find Support

    IBD
  27. First Pacific Advisors' Third-Quarter Investment in Yahoo! Increases ...

    GuruFocus
  28. Biotech Stocks Take A Beating, But Find Support

    IBD
  29. Stocks Score Small Gains; Virgin America Takes Flight

    IBD
  30. How Gilead And Johnson & Johnson's Tumble Affected These Hedge ...

    Benzinga
  31. Evercore ISI Analyst: 160,000 Patients Affected by AbbVie Hepatitis ...

    Benzinga
  32. Toys, Department Stores Rock, But Biotechs Tumble

    IBD
  33. Deutsche Bank Analyst Sees Gilead Sciences Vs. AbbVie 'Price ...

    Benzinga
  34. AbbVie Drug Displaces Gilead

    IBD
  35. Actavis, Valeant Largely Avoid Gilead's Hepatitis Dive

    IBD
  36. Express Scripts Picks AbbVie HCV Drugs Over Gilead

    IBD
  37. Express Scripts Knocks Gilead's Hepatitis C Drug in Favor of ...

    GuruFocus
  38. Bank Of America Downgrades Gilead Sciences, Sees Possible Pricing ...

    Benzinga
  39. Broad Indexes Little Changed; Facebook Breaks Out

    IBD
  40. Dow Outperforms While Nasdaq Holds Small Gain; Oil Weak

    IBD
  41. Express Scripts Picks AbbVie HCV Drugs Over Gilead

    IBD
  42. Mid-Morning Market Update: Markets Open Higher; Caesars Entertainment ...

    Benzinga
  43. Stocks Struggle To Hold Gains; Alaska Air, Spirit Up

    IBD
  44. Gilead Sciences Plummets Amid AbbVie Deal With Express Scripts

    Benzinga
  45. Stock Futures Point Higher; AbbVie Surges, Gilead Dives

    IBD
  46. AbbVie's Hep C Regimen OK'd, 12-Week Cost $83,319

    IBD
  47. How Can Drugmakers Handle New Pricing Pressures?

    IBD
  48. Are These Drugstore Retailers Good Investments?

    GuruFocus
  49. AmerisourceBergen a Key Player in the Pharma Industry

    GuruFocus
  50. Weekly 52-Week Highs Highlight: ITW, ESRX, TEVA, CHD, STI

    GuruFocus
  51. 5 Stock-Moving Medtech Events This December

    IBD
  52. Top 4 Stocks In The Health Care Plans Industry With The Highest ...

    Benzinga
  53. Surprisingly, Warren Buffett Buys These 8 Dividend Stocks

    GuruFocus
  54. Warren Buffett and CIOs Buy DirecTV, Charter Communications, ...

    GuruFocus
  55. Scour Mutual Fund Special Sections For Great Ideas

    IBD
  56. Buybacks-Driven Market: Engineered Too Far?

    YCharts
  57. #PreMarket Primer: Wednesday, October 29: Fed Likely To End Bond ...

    Benzinga
  58. Express Scripts Posts EPS In-line With Estimates

    Benzinga
  59. Stocks Tack On Gains; Centene Hits New High

    IBD
  60. AmerisourceBergen's Move To Go Big Is The Right Rx

    IBD
  61. 2015 Express Scripts Medicare Prescription Drug Plans Earn CMS ...

    Benzinga
  62. These 3 Upcoming IPOs Have Strong Investor Interest

    IBD
  63. IPO Calendar: HubSpot, Dave & Buster's Among 8 IPOs

    IBD
  64. 2 Mutual Funds Holding Hospital Stocks

    Benzinga
  65. UPDATE: Goldman Sachs Downgrades Express Scripts Holding Company

    Benzinga
  66. Benzinga's Top Downgrades

    Benzinga
  67. Goldman Sachs Downgrades Express Scripts To Neutral

    Benzinga
  68. Air Methods Navigates To Grow Medical Flight Business

    IBD
  69. Buyback ETF Slow-Footed: Better Ideas Here

    YCharts
  70. Without Its Tax Dodge, What’s Walgreen Worth?

    YCharts
  71. The Stocks Already in Correction Mode

    FoxBusiness
  72. Shares Of Express Scripts Up 5% Following Q2 Earnings

    Benzinga
  73. Quarterly “Beats”: Bah, Here Are Real Growers

    YCharts
  74. #PreMarket Primer: Tuesday, July 29: Russia Accused Of Violating ...

    Benzinga
  75. Earnings Scheduled For July 29, 2014

    Benzinga
  76. Horizon Pharma Drugs Ditched By Pharmacies; Stock Falls

    IBD
  77. Is Walgreen Set For A Better 2014?

    GuruFocus
  78. Morning Market Losers

    Benzinga
  79. Benzinga's Top #PreMarket Losers

    Benzinga
  80. Benzinga Weekly Preview: FOMC In Focus, As Earnings Season Progresses

    Benzinga
  81. Dodge & Cox Second Quarter 2014 Commentary

    GuruFocus
  82. #PreMarket Primer: Friday, July 18: Tension Between Russia And ...

    Benzinga
  83. Walgreen Tax Inversion: Masking A Weak Business?

    YCharts
  84. Merck, Gilead Lead Race To Eradicate Hepatitis C

    IBD
  85. Mid-Year Report Part Two: Not All Stocks Overpriced

    YCharts
  86. Walgreen, Rite Aid Comp Sales Beat On Pharmacies

    IBD
  87. Market Rarity: Great Company at Very Good Price

    YCharts
  88. Weekly CEO Sells Highlight: Installed Building Products Inc, ...

    GuruFocus
  89. Novo Nordisk Raises Insulin Prices As Demand Grows

    IBD
  90. Rite Aid Lowers Outlook On Drug Costs; Shares Fall

    IBD
  91. Walgreen Soars On Bigger Baskets, Scripts In May

    IBD
  92. Standout In Pharma Supply Chain’s Growth Story

    YCharts
  93. Walgreen Shares Climb Sharply in Holiday-Lifted April

    IBD
  94. Walgreen Hits Record Close On Sweet Easter Sales

    IBD
  95. Novo Nordisk lowers outlook

    IBD
  96. Novo Nordisk Struggles In U.S. Market; Q1 Sales Miss

    IBD
  97. Market Wrap For May 1: Markets Mixed To Start The New Month

    Benzinga
  98. Novo Nordisk Q1 Revenue Misses; Guidance Lowered

    IBD
  99. CVS Retail, Buyback Expected To Boost Q1 Earnings

    IBD
  100. Nasdaq Leads Early Stock Slide; Twitter Tumbles, Trinity Rises

    IBD
Trading Center